New Delhi: Fortis Healthcare said its independent director, Lt Gen Tejinder Singh Shergill, has resigned from the board due to personal reasons.
His resignation comes ahead of the crucial stakeholders’ meeting to be held on May 22 to decide the fate of four independent directors — Brian Tempest, Harpal Singh, Sabina Vaisoha and Gen Shergill.
In his mail to Fortis, Gen Shergill said: “Having previous knowledge of the company and despite my various commitments, I had agreed to join the board of Fortis Healthcare Ltd to complete the quorum as several members had left the board; Now that there are sufficient members on the board, my many commitments preclude my sparing any further time. Kindly accept my resignation from the board of Fortis Healthcare Ltd.”
Earlier in April, institutional investors — East Bridge Capital Master Fund I Ltd and National Westminster Bank Plc. as Trustee of the Jupiter India Fund had sought removal of these four directors for allegedly failing to work in the interest of all shareholders, particularly in their handling of the hospital chain’s proposed sale.
These investors have 12.04 percent stake in Fortis Healthcare Ltd.
The four directors had sent a joint representation to the shareholders of the company refuting allegations of not exercising their fiduciary duties and stated that they fairly represent interests of all shareholders.
They had also claimed that a complete change of the entire board at this time will certainly add more turbulence and ambiguity for Fortis as well as the management.
They had asked shareholders to take an informed decision while voting on a resolution seeking their removal.
These institutional investors have also sought shareholder nod for appointment of three directors — Suvalaxmi Chakraborty, Ravi Rajagopal and Indrajit Banerjee to the company’s board.
Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at email@example.com Contact no. 011-43720751